Archive for December 2017

ImmunoPrecise to Acquire Crossbeta Research BV

Victoria, British Columbia, Canada, December 22, 2017 – IMMUNOPRECISE ANTIBODIES LTD. (the “Company”) (TSX VENTURE: IPA)(OTC PINK: IPATF) announces that it has signed a binding letter of intent with Crossbeta Biosciences B.V. (“Crossbeta“) whereby the Company has agreed to acquire all of the issued and outstanding shares of Crossbeta (the “Transaction”). The Transaction continues to … Continue reading

ImmunoPrecise to Acquire ModiQuest Research BV

VICTORIA, Dec. 7, 2017 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. (the “Company”) (TSX VENTURE: IPA)(OTC PINK: IPATF) announces that it has signed a binding letter of intent with ModiQuest Research BV (“ModiQuest“) whereby the Company has agreed to acquire all of the issued and outstanding shares of ModiQuest (the “Transaction“). The Transaction continues to realize on the Board’s commitment … Continue reading

TetraGenetics and ModiQuest Collaborating for the Discovery of Therapeutic Antibodies against KCa3.1

Arlington, MA December 6, 2017 –– TetraGenetics, a biopharmaceutical company developing novel therapeutics for autoimmune diseases, today announced a collaboration with ModiQuest Research, a Dutch biotechnology company with a suite of technologies for the discovery and optimization of monoclonal antibodies, including those directed against difficult target antigens with low immunogenicity. The alliance is focused on … Continue reading

shopping basket 0 items

Shopping Cart

0

Your shopping cart is empty:

please visit the shop